President Trump and his administration have been studying new sectoral tariffs that could cover a broad part of the American ...

The expiration of the enhanced ACA premium subsidies at the end of this year is prompting many insurers to hike rates by an ...

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

Swiss drugmaker Novartis nudged up its full-year earnings forecast on Thursday, citing strong second-quarter sales of key ...

W hen Donald Trump’s tariffs are mentioned, you might recall his “Liberation Day” duties on uninhabited islands, his on-again ...

Trump said late Tuesday his administration will begin implementing pharmaceutical tariffs next month, making good on months of threats.

UBS warns Trump’s proposed US tariffs could significantly impact Greece’s exports, posing risks to growth through 2026.

UBS ranks Greece among the top three European countries most exposed to Donald Trump’s proposed 30% US tariffs, effective ...

President Trump announced new tariff rates effective Aug. 1, sending letters to multiple countries. Explore our comprehensive ...

Surging pharmaceutical imports and front-loaded shipments driven by tariff fears are reshaping North Carolina’s trade landscape, as experts ...